European Medicines Agency Revokes AbbVie's Hepatitis Drug Approval
CVS, Cigna PBMs Targeted as Lawmakers Criticize New "Anti-competitive" Move
AbbVie Withdraws Exviera From EU Market for Commercial Reasons
Express News | EMA: Abbvie Deutschland Gmbh & Co. Kg, Notified Commission of Decision to Discontinue Marketing of Exviera for Commercial Reasons
Express News | EMA: On 25 Sept European Commission Withdrew Marketing Authorisation for Exviera (Dasabuvir) in EU
AbbVie to Host Third-Quarter 2024 Earnings Conference Call